Covariate | Comparison group | Reduced model | Full model | ||||
---|---|---|---|---|---|---|---|
ORadj | (95% CI) | p-value | ORadj | (95% CI) | p-value | ||
Gender | men vs. women | deleted | - | - | 1.03 | (0.62, 1.71) | 0.906 |
Age (years) | 50–65 vs. < 50 | 0.51 | (0.23, 1.13) | 0.095 | 0.50 | (0.22, 1.15) | 0.104 |
 > 65 vs. < 50 | 0.25 | (0.14, 0.55) |  < 0.001*** | 0.23 | (0.10, 0.52) |  < 0.001*** | |
BMI (kg/m2) | overweight vs. normal | 2.54 | (1.58, 4.08) |  < 0.001*** | 2.65 | (1.63, 4.31) |  < 0.001*** |
obese vs. normal | 1.71 | (1.05, 2.89) | 0.045** | 1.78 | (1.03, 3.08) | 0.038** | |
Duration of disease (years) |  > 6 vs. ≤ 6 | 1.83 | (1.20, 2.79) | 0.005*** | 1.91 | (1.22, 2.99) | 0.005*** |
NC (cm) | Â | deleted | - | - | 1.02 | (0.96, 1.08) | 0.514 |
WC (cm) | over vs normal | deleted | - | - | 1.44 | (0.56, 3.69) | 0.451 |
SBP (mmHg) |  ≥ 140 vs. < 140 | deleted | - | - | 0.92 | (0.41, 2.07) | 0.836 |
DSP (mmHg) |  ≥ 90 vs. < 90 | deleted | - | - | 1.99 | (0.33, 2.15) | 0.456 |
Diabetes and hypertension | yes vs. no | deleted | - | - | 0.92 | (0.42, 2.04) | 0.845 |
Underlying diseases | 1 underlying disease vs. DM only | deleted | - | - | 1.32 | (0.49, 3.57) | 0.587 |
underlying disease more than 2 vs. DM only | deleted | - | - | 1.46 | (0.49, 4.32) | 0.492 | |
DR (> 12 months) | yes vs. no | deleted | - | - | 0.69 | (0.43, 1.11) | 0.127 |
DN (> 12 months) | yes vs. no | deleted | - | - | 0.63 | (0.10, 3.93) | 0.623 |
TC (mmol/l) |  ≥ 5.2 vs. < 5.2 | deleted | - | - | 1.19 | (0.62, 2.31) | 0.602 |
TG (mmol/l) |  ≥ 1.7 vs. < 1.7 | 1.81 | (1.25, 2.78) | 0.019** | 1.66 | (1.09, 2.69) | 0.037** |
HDL-C (mmol/l) |  < 1 vs. ≥ 1 | 1.16 | (0.68, 1.97) | 0.587 | 0.91 | (0.53, 1.57) | 0.738 |
LDL-C (mmol/l) |  ≥ 2.6 vs. < 2.6 | 1.55 | (1.04, 2.28) | 0.039** | 1.31 | (0.98, 2.22) | 0.007 |
ACEI or ARBs | yes vs. no | deleted | - | - | 1.01 | (0.60, 1.70) | 0.957 |
Treatment (drug use) | no drug use vs. 1–3 | deleted | - | - | 0.99 | (0.05, 2.52) | 0.993 |
no drug use vs. 4–5 | deleted | - | - | 1.05 | (0.05, 3.00) | 0.974 | |
no drug use vs. more than 6 | deleted | - | - | 0.78 | (0.04, 1.75) | 0.875 | |
Quality of care indicators | |||||||
 TOC-target indicators | yes vs. no | 0.69 | (0.43, 0.89) | 0.034** | 0.62 | (0.21, 0.82) | 0.022** |
 POC-process indicators | yes vs. no | deleted | - | - | 0.45 | (0.39, 0.51) | 0.433 |
Constant | 1.28 | (0.57, 2.90) | 0.554 | 2.16 | (0.06, 4.22) | 0.680 | |
 Hosmer–Lemeshow goodness of fit test | chi-square = 6.74, p = 0.257 | chi-square = 4.32, p = 0.899 | |||||
 LR test | -239.889 | -229.685 | |||||
 AIC | 301.254 | 431.155 | |||||
 BIC | 453.551 | 577.003 | |||||
 Pseudo-R2 | 0.311 | 0.261 | |||||
 Overall Percentage | 81.31 | 77.03% |